- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00381446
Evaluation of Corneal Staining With Various Contact Lens/Solution Combinations
September 26, 2007 updated by: Andrasko, Gary, OD, LLC
Evaluation of Corneal Staining With Market Contact Lens/Solution Combinations
The purpose of this study is to quantify the amount of corneal staining observed with various marketed contact lens/multipurpose solution combinations.
The hypothesis is that there are measurable differences in the amount of corneal staining between the various combinations.
Study Overview
Status
Unknown
Conditions
Intervention / Treatment
Detailed Description
A series of clinical studies is being conducted at one research site using a double-masked, randomized cross-over design.
Each study consists of asymptomatic daily wear soft contact lens wearers observed at baseline and at two and four hours post lens insertion.
Corneal staining is being assessed using sodium fluorescein, a cobalt filter and a yellow filter.
Subjective comfort assessments are obtained at each visit.
Study Type
Interventional
Enrollment (Anticipated)
200
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Gary J. Andrasko, OD, MS
- Phone Number: 614-459-3363
- Email: gandrask@columbus.rr.com
Study Locations
-
-
Ohio
-
Columbus, Ohio, United States, 43213
- Recruiting
- Dr. Richard Erdey office
-
Contact:
- Gary J. Andrasko, OD, MS
- Phone Number: 614-459-3363
- Email: gandrask@columbus.rr.com
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Description
Inclusion Criteria:
- currently wearing soft contact lenses daily wear for at least 2 weeks prior to study
- correct visual acuity of 20/30 or better each eye
Exclusion Criteria:
- history of hypersensitivity to any components of solution being tested
- any ocular condition prohibiting contact lens wear
- excessive baseline staining as defined in protocol
- use of topical or OTC ocular medications during the study
- seasonal allergies with significant effect on contact lens wear
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Diagnostic
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: Double
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
---|
Area of Corneal Staining
|
Secondary Outcome Measures
Outcome Measure |
---|
Type (severity) of Corneal Staining
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Investigators
- Principal Investigator: Gary J. Andrasko, OD, MS
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
July 1, 2005
Study Completion (Anticipated)
March 1, 2008
Study Registration Dates
First Submitted
September 25, 2006
First Submitted That Met QC Criteria
September 25, 2006
First Posted (Estimate)
September 27, 2006
Study Record Updates
Last Update Posted (Estimate)
September 27, 2007
Last Update Submitted That Met QC Criteria
September 26, 2007
Last Verified
September 1, 2007
More Information
Terms related to this study
Other Study ID Numbers
- MS005
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Corneal Staining
-
Coopervision, Inc.CompletedCorneal StainingUnited States
-
Abbott Medical OpticsCompletedCorneal StainingUnited States
-
Alcon ResearchCompleted
-
Innovative MedicalCompletedCorneal StainingUnited States
-
Innovative MedicalCompletedCorneal StainingUnited States
-
Southern California College of Optometry at Marshall...CompletedContact Lens-induced Corneal Fluorescein StainingUnited States
-
Alcon ResearchCompletedCorneal StainingUnited States
-
Johnson & Johnson Vision Care, Inc.CompletedVisual Acuity, Slit Lamp Biomicroscopy (Corneal Staining Assessment)United States
-
Southern California College of Optometry at Marshall...Ohio State University; University of Houston; Alcon Research; University of Waterloo and other collaboratorsCompletedContact Lens Complication | Contact Lens Acute Red Eye | Contact Lens Related Corneal Infiltrate (Disorder) | Contact Lens-Induced Corneal Fluorescein StainingUnited States, Canada
-
Glia, LLCCompletedContact Lens Discomfort | Contact Lens-induced Corneal Disorder | Contact Lens Acute Red Eye | Contact Lens-induced Corneal Fluorescein StainingUnited States
Clinical Trials on Marketed contact lens care products
-
Johnson & Johnson Vision Care, Inc.Completed
-
Johnson & Johnson Vision Care, Inc.Completed
-
Johnson & Johnson Vision Care, Inc.Completed
-
Johnson & Johnson Vision Care, Inc.Completed
-
Johnson & Johnson Vision Care, Inc.CompletedVision DisordersUnited States
-
Johnson & Johnson Vision Care, Inc.Completed
-
Bausch & Lomb IncorporatedCompleted
-
Johnson & Johnson Vision Care, Inc.Terminated
-
Johnson & Johnson Vision Care, Inc.Completed
-
Bausch & Lomb IncorporatedCompleted